Mohammadi M, Schlessinger J, Hubbard S R
Department of Pharmacology, New York University Medical Center, New York 10016, USA.
Cell. 1996 Aug 23;86(4):577-87. doi: 10.1016/s0092-8674(00)80131-2.
The crystal structure of the tyrosine kinase domain of fibroblast growth factor receptor 1 (FGFR1K) has been determined in its unliganded form to 2.0 angstroms resolution and in complex with with an ATP analog to 2.3 angstrosms A resolution. Several features distinguish the structure of FGFR1K from that of the tyrosine kinase domain of the insulin receptor. Residues in the activation loop of FGFR1K appear to interfere with substrate peptide binding but not with ATP binding, revealing a second and perhaps more general autoinhibitory mechanism for receptor tyrosine kinases. In addition, a dimeric form of FGFR1K observed in the crystal structure may provide insights into the molecular mechanisms by which FGF receptors are activated. Finally, the structure provides a basis for rationalizing the effects of kinase mutations in FGF receptors that lead to developmental disorders in nematodes and humans.
成纤维细胞生长因子受体1(FGFR1K)酪氨酸激酶结构域的晶体结构已被确定,其未结合配体形式的分辨率为2.0埃,与ATP类似物结合的复合物分辨率为2.3埃。FGFR1K的结构有几个特征与胰岛素受体酪氨酸激酶结构域不同。FGFR1K激活环中的残基似乎会干扰底物肽的结合,但不影响ATP的结合,这揭示了受体酪氨酸激酶的第二种且可能更普遍的自抑制机制。此外,晶体结构中观察到的FGFR1K二聚体形式可能有助于深入了解FGF受体被激活的分子机制。最后,该结构为解释导致线虫和人类发育障碍的FGF受体激酶突变的影响提供了基础。